These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30675231)

  • 1. Expression and selective activation of somatostatin receptor subtypes induces cell cycle arrest in cancer cells.
    Zou Y; Tan H; Zhao Y; Zhou Y; Cao L
    Oncol Lett; 2019 Feb; 17(2):1723-1731. PubMed ID: 30675231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
    Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
    Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin and its receptor family.
    Patel YC
    Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells.
    Watt HL; Kumar U
    Cancer Cell Int; 2006 Mar; 6():5. PubMed ID: 16519802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between somatostatin receptor subtype expression and clinicopathology, Ki-67, Bcl-2 and p53 in colorectal cancer.
    Qiu CZ; Wang C; Huang ZX; Zhu SZ; Wu YY; Qiu JL
    World J Gastroenterol; 2006 Apr; 12(13):2011-5. PubMed ID: 16610049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.
    Rocheville M; Lange DC; Kumar U; Sasi R; Patel RC; Patel YC
    J Biol Chem; 2000 Mar; 275(11):7862-9. PubMed ID: 10713101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: an immunohistochemical analysis.
    Kumar U
    Neuroscience; 2005; 134(2):525-38. PubMed ID: 15961235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
    Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
    Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
    Xie YM; Yan LN; Wei B; Guo MM; Tang CW
    Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, NADPH-diaphorase (NADPH-d), and tyrosine hydroxylase in the rat hypothalamus.
    Kumar U
    J Comp Neurol; 2007 Sep; 504(2):185-205. PubMed ID: 17626271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation.
    Morichetti D; Mazzucchelli R; Santinelli A; Stramazzotti D; Lopez-Beltran A; Scarpelli M; Bono AV; Cheng L; Montironi R
    Int J Immunopathol Pharmacol; 2010; 23(2):511-22. PubMed ID: 20646346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
    Barbieri F; Pattarozzi A; Gatti M; Porcile C; Bajetto A; Ferrari A; Culler MD; Florio T
    Endocrinology; 2008 Sep; 149(9):4736-46. PubMed ID: 18566118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas.
    Bläker M; Schmitz M; Gocht A; Burghardt S; Schulz M; Bröring DC; Pace A; Greten H; De Weerth A
    J Hepatol; 2004 Jul; 41(1):112-8. PubMed ID: 15246216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
    Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
    Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
    Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells.
    Watt HL; Kharmate GD; Kumar U
    Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.